UM

Browse/Search Results:  1-7 of 7 Help

Selected(0)Clear Items/Page:    Sort:
Standard: Human intestinal cancer organoids Other
2023-12-01
Authors:  ; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1 | Submit date:2023/08/03
Standard: Human intestinal organoids Other
2023-06-14
Authors:  Yalong Wang;  Hanqing Lin;  Lianzheng Zhao;  Fan Hong;  Jie Hao; et al.
Favorite | TC[WOS]:3 TC[Scopus]:5 | Submit date:2023/08/03
The tick saliva peptide HIDfsin2 promotes the tick-borne virus SFTSV replication in vitro by enhancing p38 signal pathway Journal article
Wang, Luyao, Sun, Fang, Hu, Jing, Zuo, Weimin, Zheng, Yi, Wu, Yingliang, Kwok, Hang Fai, Cao, Zhijian. The tick saliva peptide HIDfsin2 promotes the tick-borne virus SFTSV replication in vitro by enhancing p38 signal pathway[J]. Archives of Toxicology, 2023, 97, 1783-1794.
Authors:  Wang, Luyao;  Sun, Fang;  Hu, Jing;  Zuo, Weimin;  Zheng, Yi; et al.
Favorite | TC[WOS]:3 TC[Scopus]:3  IF:4.8/5.3 | Submit date:2023/07/20
Antiviral Strategy  P38 Activation  Promotion  Sftsv  Tick Saliva Peptide  
P38 activation and viral infection Journal article
Wang, Luyao, Xia, Zhiqiang, Tang, Wei, Sun, Yu, Wu, Yingliang, Kwok, Hang Fai, Sun, Fang, Cao, Zhijian. P38 activation and viral infection[J]. Expert Reviews in Molecular Medicine, 2022, 24.
Authors:  Wang, Luyao;  Xia, Zhiqiang;  Tang, Wei;  Sun, Yu;  Wu, Yingliang; et al.
Favorite | TC[WOS]:12 TC[Scopus]:14  IF:4.5/5.6 | Submit date:2022/02/21
Activation  Antiviral Target  Infection  P38 Mapk  Virus  
Capivasertib restricts sars-cov-2 cellular entry: A potential clinical application for covid-19 Journal article
Fang Sun, Chenglin Mu, Hang Fai Kwok, Jiyuan Xu, Yingliang Wu, Wanhong Liu, Jean-Marc Sabatier, Cédric Annweiler, Xugang Li, Zhijian Cao, Yingqiu Xie. Capivasertib restricts sars-cov-2 cellular entry: A potential clinical application for covid-19[J]. International Journal of Biological Sciences, 2021, 17(9), 2348-2355.
Authors:  Fang Sun;  Chenglin Mu;  Hang Fai Kwok;  Jiyuan Xu;  Yingliang Wu; et al.
Favorite | TC[WOS]:33 TC[Scopus]:31  IF:8.2/8.3 | Submit date:2022/05/13
Akt Inhibitor  Antiviral Activity  Capivasertib  Covid-19  Sars-cov-2  
Inhibitory activity of a scorpion defensin BmKDfsin3 against hepatitis C virus Journal article
Cheng,Yuting, Sun,Fang, Li,Songryong, Gao,Minjun, Wang,Luyao, Sarhan,Moustafa, Abdel-Rahman,Mohamed A., Li,Wenxin, Kwok,Hang Fai, Wu,Yingliang, Cao,Zhijian. Inhibitory activity of a scorpion defensin BmKDfsin3 against hepatitis C virus[J]. Antibiotics-Basel, 2020, 9(1), 33.
Authors:  Cheng,Yuting;  Sun,Fang;  Li,Songryong;  Gao,Minjun;  Wang,Luyao; et al.
Favorite | TC[WOS]:18 TC[Scopus]:20  IF:4.3/4.6 | Submit date:2021/03/04
Hepatitis c Virus (Hcv)  P38  Scorpion Defensin  
Recombinant Nogo-66 via soluble expression with SUMO fusion in Escherichia coli inhibits neurite outgrowth in vitro Journal article
Dai,Xiaoyong, Sun,Zhongqing, Liang,Rui, Li,Yu, Luo,Huanmin, Huang,Yadong, Chen,Meiwan, Su,Zhijian, Xiao,Fei. Recombinant Nogo-66 via soluble expression with SUMO fusion in Escherichia coli inhibits neurite outgrowth in vitro[J]. Applied Microbiology and Biotechnology, 2015, 99(14), 5997-6007.
Authors:  Dai,Xiaoyong;  Sun,Zhongqing;  Liang,Rui;  Li,Yu;  Luo,Huanmin; et al.
Favorite | TC[WOS]:6 TC[Scopus]:7  IF:3.9/4.9 | Submit date:2021/03/01
Bioassay  Expression  Nogo-66  Purification  Small Ubiquitin-related Modifier